Development of Pharmacokinetics Model in Pregnancy Women and Fetus

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01916330

Enrollment

Registered

2013-08-05

Start date

2013-01-14

Completion date

Unknown

Last updated

2019-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Labor, Preterm Premature Rupture of Membrane (PPROM)

Brief summary

Pharmacokinetics analysis and development of pharmacokinetics model in pregnancy women and fetus

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 50 Years

Healthy volunteers

Inclusion criteria

* 20 \<= age \< 50 * pregnant women who were administered intramuscular dexamethasone (ex) preterm labor) * pregnant women who were administered PO clarithromycin (ex) PPROM/intrauterine infection or inflammation)

Exclusion criteria

* who deny the study entrance * who administered study drug before transfer to tertiary hospital

Design outcomes

Primary

Measure	Time frame	Description
Analysis of drug concentration	Day 1 after delivery	drug (dexamethasone, clarithromycin)

Countries

South Korea

Outcome results